skip navigation

Skip Nav

HIV/AIDS Clinical Trials

Clinical Trial Search Results

148 studies were found about Complications/Side Effects, Lipodystrophy

A Study of Physical and Metabolic Abnormalities in HIV Infected and Uninfected Children and Youth

Condition: HIV Infections; HIV-Associated Lipodystrophy Syndrome; HIV Lipodystrophy Syndrome; Lipodystrophy; Dyslipidemia; Osteoporosis; Osteopenia

NCT ID: NCT00069004

Facial Lipoatrophy Trial: Immediate Versus Deferred Injections of Poly-L-Lactic Acid for HIV Facial Lipoatrophy

Condition: HIV-Associated Lipodystrophy; HIV Infections

NCT ID: NCT00126308

Evaluation of the Occurrence of Lipoatrophy in HIV-1 Infected Naive Patients

Condition: HIV Infections; HIV-Associated Lipodystrophy Syndrome

NCT ID: NCT00122668

Effect of Pioglitazone on HIV-1 Related Lipoatrophy: a Randomized, Double Blind, Placebo-Controlled Trial in 130 Patients

Condition: HIV-Associated Lipodystrophy Syndrome; HIV Infections

NCT ID: NCT00148850

Polyacrylamide Hydrogel Injection in HIV-related Lipoatrophy

Condition: HIV Infection; Antiretroviral Side Effects; Lipodystrophy Syndrome Related to HIV Infection

NCT ID: NCT01077765

Growth Hormone and/or Rosiglitazone for HIV-Associated Increased Abdominal Fat and Insulin Resistance

Condition: HIV-Associated Lipodystrophy Syndrome; Insulin Resistance; HIV Infections; Metabolic Syndrome X; Body Weight Changes

NCT ID: NCT00130286

Effects of Growth Hormone Releasing Hormone in HIV

Condition: HIV; HIV Lipodystrophy

NCT ID: NCT01263717

Effectiveness of Nucleoside Supplementation and Substituting Tenofovir Disoproxil Fumarate for Other Drugs in Anti-HIV Regimens in Reversing Fat Loss in HIV Infected Adults

Condition: HIV Infections; Lipodystrophy; Metabolic Diseases; Nutrition Disorders

NCT ID: NCT00119379

Safety and Efficacy of Intradermal Injections of Newfill Versus Eutrophill in the Treatment of Facial Lipoatrophy in HIV-infected Patients ANRS 132 SMILE

Condition: HIV-Associated Lipodystrophy Syndrome

NCT ID: NCT00383734

HIV Infection And Metabolic Abnormalities Protocol 1 (HAMA001)

Condition: HIV-Associated Lipodystrophy Syndrome; Cardiovascular Disease

NCT ID: NCT00192660

Strategies of Interruption/Reinitiation of Antiretroviral Therapy in HIV-Infected Patients With Lipodystrophy

Condition: HIV-Associated Lipodystrophy Syndrome

NCT ID: NCT00646984

Comparing a Nucleoside-Analogue-Sparing Regimen and a Protease-Inhibitor-Sparing Regimen in HIV Infected Patients

Condition: HIV-Associated Lipodystrophy Syndrome

NCT ID: NCT00135460

TH9507 Extension Study in Patients With HIV- Associated Lipodystrophy

Condition: Lipodystrophy; HIV Infections

NCT ID: NCT00608023

The Effect of Anti-HIV Treatment on Body Characteristics of HIV-Infected Children

Condition: HIV Infections; HIV Wasting Syndrome; Lipodystrophy

NCT ID: NCT00006064

TH9507 in Patients With HIV-Associated Lipodystrophy

Condition: HIV Infections; Lipodystrophy

NCT ID: NCT00123253

Mechanisms of Lipodystrophy in HIV-Infected Pateints

Condition: HIV Infections

NCT ID: NCT00457665

Study Evaluating the Impact on Fat Distribution of Nucleoside Reverse Transcriptase Inhibitor (NRTI)-Sparing Regimens in Antiretroviral Experienced Patients With Lipoatrophy

Condition: HIV Infections; HIV Lipodystrophy Syndrome

NCT ID: NCT00122655

Leptin for Abnormal Lipid Kinetics in HIV Lipodystrophy Syndrome

Condition: HIV Lipodystrophy

NCT ID: NCT01511016

HIV Acquired Lipodystrophy (HAL) Classification, Measurement and Fat Response to Thiazolidinedione (TZD) (Pioglitazone)

Condition: HIV Infections

NCT ID: NCT01023620

Psychological Morbidity and Facial Volume in HIV Lipodystrophy: Quantification of Treatment Outcome

Condition: HIV-Associated Lipodystrophy Syndrome

NCT ID: NCT01359917

Clinical Trial to Assess the Effect of the Change of Efavirenz (EFV) for Lopinavir/Ritonavir (LPV/r) in Lipoatrophy in HIV-infected Patients

Condition: HIV Infections; Lipoatrophy

NCT ID: NCT00978237

Physiologic Growth Hormone Effects in HIV Lipodystrophy

Condition: AIDS; HIV Infections

NCT ID: NCT00100698

A Study of Increased Lactic Acid and Abnormal Fat Distribution in HIV-Positive Patients

Condition: HIV Infections; Lipodystrophy

NCT ID: NCT00005764

The Effects of Anabolic Steroids and Protease Inhibitors on People Living With HIV/AIDS

Condition: HIV; AIDS; Lipodystrophy; Hyperlipidemia

NCT ID: NCT00202241

Prevention of Lipoatrophy in Patients Treated With Lopinavir/Ritonavir in Monotherapy Versus ZDV + 3TC + ABC

Condition: HIV Infection; HIV Infections

NCT ID: NCT00865475

Study Comparing Reducing the Dose of Stavudine Versus Switching to Tenofovir in HIV-Infected Patients Receiving Antiretroviral Therapy

Condition: HIV Infections; Lipoatrophy

NCT ID: NCT00312832

Switching From Zidovudine to an NNRTI or Lopinavir/Ritonavir in Patients Treated With Zidovudine/ Lamivudine/Abacavir.

Condition: HIV Associated Lipodystrophy Syndrome.; HIV; Hypercholesterolemia; Lipoatrophy

NCT ID: NCT00139178

A Study to Determine How and Why HIV-Infected Subjects on Anti-viral Treatment Develop Lipodystrophy

Condition: HIV Infections; Lipodystrophy

NCT ID: NCT00006190

Effects of a Uridine Supplement on HIV Infected Adults With Lipoatrophy

Condition: HIV Infections; Lipoatrophy

NCT ID: NCT00307164

Role of the Autonomic Nervous System in HIV-Lipodystrophy

Condition: HIV Infections; Lipodystrophy-Syndrome

NCT ID: NCT00149097

Compassionate Use Study of Two Dose Levels of Thalidomide in Adults With HIV Wasting Syndrome

Condition: HIV Infections; HIV Wasting Syndrome

NCT ID: NCT00002157

Study of Reyataz in HIV-infected Patients With Lipodystrophy Syndrome

Condition: HIV-Associated Lipodystrophy Syndrome

NCT ID: NCT00135356

Switching From Efavirenz to Atazanavir/ Ritonavir in HIV-infected Subjects With Good Virologic Suppression

Condition: HIV Infection; Mitochondrial Dysfunction

NCT ID: NCT01194856

HIV Fat Redistribution and the Evaluation of Brown Fat

Condition: HIV Infections

NCT ID: NCT01098045

A Study of Megestrol Acetate Alone or in Combination With Testosterone Enanthate Drug in the Treatment of HIV-Associated Weight Loss

Condition: HIV Infections; HIV Wasting Syndrome

NCT ID: NCT00001079

A Phase I/II Study to Evaluate Single Agent and Combination Therapy With Megestrol Acetate and Dronabinol for the Treatment of HIV-Wasting Syndrome

Condition: Cachexia; HIV Infections; HIV Wasting Syndrome

NCT ID: NCT00000737

A Phase II, Parallel Group, Randomized, Placebo-Controlled Study of the Safety and Efficacy of Thalidomide in Reducing Weight Loss in Adults With HIV Wasting Syndrome

Condition: HIV Infections; HIV Wasting Syndrome

NCT ID: NCT00002127

Treatment of Abnormal Adipose Tissue Accumulation in HIV Patients

Condition: HIV Infections; Lipodystrophy

NCT ID: NCT00082628

Yoga for the Management of HIV-Metabolic Syndromes

Condition: HIV Infections; HIV Metabolic Cardiovascular Syndrome; HIV Lipodystrophy; HIV Metabolic Syndromes; Hypertension

NCT ID: NCT00627380

Lopinavir/r Monotherapy Versus Abacavir/Lamivudine and Lopinavir/r for Limb Fat Recovery in Persons With Lipoatrophy

Condition: HIV Infection; Lipodystrophy; HIV Infections

NCT ID: NCT00865007

Diet, Exercise, Niacin, and Fenofibrate to Reduce Heart Disease Risk Factors in Individuals With HIV Lipodystrophy or Dyslipidemia

Condition: Cardiovascular Diseases; Heart Diseases; HIV Infections; Hyperlipidemia; Hypertriglyceridemia; Insulin Resistance; Atherosclerosis

NCT ID: NCT00246376

Raltegravir Therapy for Women With HIV and Fat Accumulation

Condition: HIV Infections; Lipodystrophy

NCT ID: NCT00656175

Effects of Treatment Changes on Fat Wasting in the Arms and Legs of HIV Patients

Condition: HIV Infections; Lipodystrophy; Wasting Disease

NCT ID: NCT00028314

Observational Study of Fat Loss in HIV Infected Adults Taking Nucleoside Reverse Transcriptase Inhibitors (NRTIs)

Condition: HIV Infections; Lipodystrophy; Metabolic Diseases; Nutrition Disorders

NCT ID: NCT00119405

Observational Study of Changes in Fat Distribution and Blood Metabolites in HIV Infected Adults

Condition: HIV Infections; Lipodystrophy; Diabetes; Hyperlipidemia; Atherosclerosis

NCT ID: NCT00331448

Pravastatin for Hyperlipidaemia in HIV.

Condition: HIV Infections; Lipid Metabolism; Glucose Metabolism; Metabolic Abnormality; Lipodystrophy; Cardiovascular Disease

NCT ID: NCT00227500

Seronegatives and Metabolic Abnormalities Protocol 2 (SAMA002): Study to Compare the Effect of Kaletra and Combivir® in HIV-Negative Healthy Subjects

Condition: HIV Infections; Dyslipidemias; Glucose Metabolism Disorders; Metabolic Diseases; Lipodystrophy; Cardiovascular Disease

NCT ID: NCT00192621

Metabolic Abnormalities in HIV-infected Persons

Condition: Lipodystrophy; HIV Infection

NCT ID: NCT01612858

The Effect of Low-Dose Human Growth Hormone Therapy in HIV Infected Patients

Condition: HIV Infections; Lipodystrophy

NCT ID: NCT00119769

MEDICLAS Study (Metabolic Effects of Different Classes of AntiretroviralS)

Condition: HIV Infections; HIV-Associated Lipodystrophy Syndrome

NCT ID: NCT00122226

Artefill for the Treatment of HIV-associated Facial Lipoatrophy

Condition: HIV-facial Lipoatrophy

NCT ID: NCT02009462

Growth Hormone in the Treatment of HIV-Associated Wasting

Condition: HIV Infections; HIV Wasting Syndrome

NCT ID: NCT00489528

Rosiglitazone Effect on Mitochondria and Lipoatrophy

Condition: HIV Infections

NCT ID: NCT00367744

Evaluate Weight Gain Using 2 Different Formulations of Megestrol Acetate Oral Suspension for AIDS-Related Weight Loss

Condition: HIV Infections; Unintended Weight Loss; Cachexia; Anorexia; AIDS Wasting Syndrome; HIV Wasting Syndrome

NCT ID: NCT00637572

A Comparison of Body Fat Distribution in HIV-1 Infected Patients Receiving, Since the Beginning and for at Least Two Years, an Antiretroviral Therapy Based on Efavirenz or Lopinavir/Ritonavir Combined With Tenofovir + Emtricitabine or Lamivudine

Condition: HIV Infection

NCT ID: NCT01159743

A Study to Evaluate the Effect of Nandrolone Decanoate in Women With HIV-Associated Weight Loss

Condition: HIV Infections; HIV Wasting Syndrome

NCT ID: NCT00000854

Eplerenone in HIV Associated Abdominal Fat Accumulation

Condition: HIV

NCT ID: NCT01405456

Randomized Placebo-Controlled Study of Aerobic Exercise and Resistance Training Plus Megestrol Acetate for HIV-Wasting

Condition: Acquired Immunodeficiency Syndrome; HIV Wasting Syndrome; HIV Infections

NCT ID: NCT00004664

PREventing Progression of Adipose Tissue Redistribution

Condition: HIV Infections

NCT ID: NCT00389194

Underlying Abnormalities in Fat and Muscle Leading to Lipodystrophy Syndrome

Condition: HIV Infections; Lipodystrophy; Insulin Resistance

NCT ID: NCT00006185

SHARE: Simple HAART With Abacavir, Reyataz, and Epivir

Condition: HIV Infections; Lipodystrophy

NCT ID: NCT00426296

Follow-up on the HIGH: Low Study - the Longterm Effects of Growth Hormone

Condition: HIV Infections; HIV-Associated Lipodystrophy Syndrome

NCT ID: NCT00662181

Nevirapine or Atazanavir/Ritonavir Given With Emtricitabine/Tenofovir in Human Immunodeficiency Virus (HIV)-1-infected Treatment Naive Adults

Condition: HIV Infections

NCT ID: NCT00389207

Effects of IGF-I in HIV Metabolic Disease

Condition: HIV Lipodystrophy

NCT ID: NCT01329744

Effects of Short-term Growth Hormone in HIV-infected Patients

Condition: HIV Lipodystrophy

NCT ID: NCT00795210

Therapeutic Approaches to HAART-Induced Lipodystrophy

Condition: HIV Infections; Lipodystrophy

NCT ID: NCT00461552

Evaluation of Raltegravir Plus Maraviroc Therapy in Controlled HIV Patients Presenting With Lipohypertrophy

Condition: Human Immunodeficiency Virus; Lipohypertrophy

NCT ID: NCT01420523

Proton Magnetic Resonance Spectroscopy (1H MRS) in Evaluating the Bone Marrow, Muscle and Adipose Tissue on Normal and Human Immunodeficiency Virus Infected Subjects

Condition: Acquired Immunodeficiency Syndrome; Lipodystrophy

NCT ID: NCT00172315

Exercise and Pioglitazone for HIV-Metabolic Syndromes

Condition: HIV Infections; Type 2 Diabetes; Obesity; HIV; AIDS; Cardiovascular Disease; Lipodystrophy

NCT ID: NCT00639457

Myocardial Function & FFA Metabolism in HIV Metabolic Syndrome

Condition: HIV Infections; Cardiovascular Disease; Insulin Resistance; HIV Lipodystrophy; The Metabolic Syndrome

NCT ID: NCT00656851

Nutritional and Metabolic Disorders in HIV Infected Children and Adolescent

Condition: HIV-1

NCT ID: NCT01771562

Metabolism and Body Shape of Healthy Children and Children With Chronic Infections

Condition: HIV Infections; Healthy; Hyperlipidemia; Lipodystrophy

NCT ID: NCT00001142

Long-term Observational Study in HIV Subjects Exposed to EGRIFTA®

Condition: HIV

NCT ID: NCT01579695

Pilot Study of Raltegravir Lipodystrophy IISP

Condition: HIV Infection

NCT ID: NCT01164605

Lactate Metabolism Study in HIV Infected Persons

Condition: HIV Infections; AIDS; Lactic Acidosis; Lipodystrophy

NCT ID: NCT00202228

Exercise for Patients With HIV Infections

Condition: HIV Infections; Lipodystrophy; Inflammation

NCT ID: NCT00910936

HIV and Fat Accumulation

Condition: HIV Infection

NCT ID: NCT01088295

A Study of Amprenavir in Patients With Protease Inhibitor-Related Complications

Condition: HIV Infections

NCT ID: NCT00002417

Perceived Changes in Body Build and Image in Patients Who Are Now Taking or Recently Have Stopped Taking Anti-HIV Drugs

Condition: HIV Infections; Lipodystrophy

NCT ID: NCT00006290

The Effect of Efavirenz and Nelfinavir on the Blood Levels of Certain Lipid-Lowering Drugs

Condition: HIV Infections; HIV Seronegativity; Lipodystrophy

NCT ID: NCT00017758

Safety and Effectiveness of Fenofibrate and Pravastatin in HIV-Positive Patients With Abnormal Blood Lipids

Condition: HIV Infections; Lipodystrophy

NCT ID: NCT00006412

Metformin and Rosiglitazone, Alone or in Combination, in HIV-Infected Patients With Insulin and Fat Abnormalities

Condition: HIV Infections; Lipodystrophy; Hyperinsulinemia

NCT ID: NCT00015691

The Use of Nutropin Depot in HIV-Infected Adult Males

Condition: HIV Infection

NCT ID: NCT00286676

Study of Lifestyle Modification in HIV Lipodystrophy

Condition: HIV; Metabolic Diseases

NCT ID: NCT00111358

SNAP: Switching Nucleoside Analogues Protocol - Lipoatrophy and Mitochondrial Function

Condition: HIV Infection

NCT ID: NCT00225082

Nutrition Intervention in AIDS Wasting

Condition: HIV Wasting Syndrome

NCT ID: NCT00006167

Long Term Treatment Interruptions

Condition: HIV Infections; AIDS

NCT ID: NCT00433056

A Study to Evaluate High Protein Supplementation in HIV-Positive Patients With Stable Weight Loss

Condition: HIV Infections; HIV Wasting Syndrome

NCT ID: NCT00000925

Rosiglitazone and Exercise Training: Effects on HIV-Infected People With Insulin Resistance, Hypertriglyceridemia, and Adipose Tissue Maldistribution

Condition: HIV Infections; Insulin Resistance

NCT ID: NCT00025753

HIV Posterior Cheek Enlargement

Condition: HIV Posterior Cheek Enlargement

NCT ID: NCT01635504

Changing to Nonprotease Inhibitor Treatment to Improve Side Effects

Condition: HIV Infections; Lipodystrophy

NCT ID: NCT00021463

An Study to Investigate the Recovery, Excretion, and Pharmacokinetics of 14C-GSK1265744 Administered as a Single Oral Dose and a Study to Describe the Pharmacokinetics of a Supratherapeutic Dose of GSK1265744 in Healthy Adult Subjects

Condition: HIV-associated Lipodystrophy Syndrome

NCT ID: NCT01848340

Combination of Insulin Sensitizer and Leptin as Treatment for the HAART -Induced Metabolic Syndrome

Condition: HIV Lipodystrophy

NCT ID: NCT00362440

Acipimox to Improve Hyperlipidemia and Insulin Sensitivity Associated With HIV

Condition: Insulin Resistance; Cardiovascular Diseases; Heart Diseases; HIV Infections; Hypertriglyceridemia; Hyperlipidemia

NCT ID: NCT00246402

Safety, Efficacy and Psychological Effects of Treating Antiretroviral Drug-Induced Facial Lipoatrophy With Bio-Alcamid

Condition: Human Immunodeficiency Virus; Facial Lipoatrophy

NCT ID: NCT00333684

Clinical, Virological and Safety Outcomes of a Lopinavir/Ritonavir-Based Regimen in HIV-1 Infected Patients in Routine Clinical Use in China

Condition: HIV-1 Infections

NCT ID: NCT01074931

Rosiglitazone in the Treatment of HIV-Associated Hyperlipidemia

Condition: HIV Infections; Hyperlipidemia

NCT ID: NCT00006493

BMS-Reyataz Study in Treatment in Naive Subjects to Compare the Efficacy and Safety Between Boosted Reyataz and Kaletra When in Combination With Fixed Dose Truvada

Condition: HIV Infections

NCT ID: NCT00272779

Analysis of Changes in Adipose Tissue of Patients With Lipoatrophy HIV Infection Treated With Nucleoside Thymidine, After Switching to Monotherapy With Lopinavir / Ritonavir

Condition: HIV Infections

NCT ID: NCT01031849

Metabolic Effects of Non-Thymidine Analogue Anti-HIV Medications

Condition: HIV Infections

NCT ID: NCT00433992

Study of Home-Based Resistance and Strength Training in HIV-Infected Women

Condition: HIV Infections

NCT ID: NCT00111332

Study on the Effect of Kaletra + Nevirapine as Maintenance Bitherapy Compared to a Triple Therapy Including Kaletra + Analogues in HIV Patients

Condition: HIV Infections

NCT ID: NCT00335686

Diabetic Retinopathy in HIV Subjects Treated With EGRIFTA®

Condition: Diabetic Retinopathy; HIV

NCT ID: NCT01591902

Facial Lipoatrophy Correction Experience With SCULPTRA ("FACES" Study)

Condition: Facial Lipoatrophy

NCT ID: NCT00360932

A Comparison of Two Caloric Supplements in the Prevention of Weight Loss in Patients With AIDS Who Take Daily Multivitamin and Mineral Supplements

Condition: HIV Infections; HIV Wasting Syndrome

NCT ID: NCT00001077

BASTA Study on STI in HIV Infected Patients

Condition: HIV Infection

NCT ID: NCT00310245

Epidermal Nerve Fiber Density, Fat and Mitochondrial Parameters in Thai HIV+ Patients on d4T and HIV- Patients

Condition: HIV

NCT ID: NCT01178684

Relationship Between Fatigue and Mitochondrial Damage in Patients With HIV/AIDS

Condition: HIV Infections; Fatigue; HIV Positive; AIDS; Healthy Volunteer; HV

NCT ID: NCT00106795

Evaluation of Albuminuria HIV-Infected Patients

Condition: HIV-Associated Focal Segmental Glomerulosclerosis; HIV-Associated Collapsing Glomerulopathy; Proteinuria; Albuminuria; Renal Tubular Toxicity

NCT ID: NCT00524992

Effects of Growth Hormone in Chronically Ill Children

Condition: - Hurler Syndrome (MPS-1) With Short Stature and Muscle Wasting; - Cerebral Palsy With Muscle Wasting; - Juvenile Rheumatoid Arthritis With Muscle Wasting and Short Stature; - Crohn’s Disease; - HIV Infection.

NCT ID: NCT00286689

A Comparison of Three Anti-HIV Drug Combinations in HIV-Infected Patients

Condition: HIV Infections

NCT ID: NCT00005106

AIDS Wasting in Women: Anabolic Effects of Testosterone

Condition: AIDS Wasting Syndrome

NCT ID: NCT00006158

A Study to Evaluate the Use of a Protease Inhibitor and of Interleukin-2 (IL-2) in the Treatment of Early HIV Infection

Condition: HIV Infections

NCT ID: NCT00006154

Endothelial Dysfunction as a Risk Factor in HIV Study

Condition: HIV Infections

NCT ID: NCT00039663

Randomized, Placebo-Controlled Study of Leptin for the Treatment of HIV Lipodystrophy and Metabolic Syndrome

Condition: HAART-induced Lipodystrophy and Metabolic Syndrome

NCT ID: NCT00140244

Magnetic Resonance Imaging of the Face and Bones

Condition: HIV Infection

NCT ID: NCT00001762

Metabolomics Fingerprinting and Metabolic Dynamis After HIV Infection

Condition: HIV

NCT ID: NCT01828268

Post-Licensure Safety Study of ISENTRESS™ in a US Managed Care Network (MK-0518-268)

Condition: HIV-1 Infections

NCT ID: NCT01078246

Long-Term Data Collection From Participants in Adult AIDS Clinical Trials

Condition: HIV Infections

NCT ID: NCT00001137

BASIC: Boosted Atazanavir or Saquinavir Induced Lipid Changes

Condition: HIV Infections

NCT ID: NCT00389402

Evaluation of Three Strategies of Second-line Antiretroviral Treatment in Africa (Dakar - Bobo-Dioulasso - Yaoundé)

Condition: HIV; HIV Infections

NCT ID: NCT00928187

Study to Evaluate the Activity and Tolerability of Lopinavir/Ritonavir and Lamivudine Bitherapy in HIV Patients With Viral Suppression

Condition: HIV Infection

NCT ID: NCT01471821

The First Failure Study

Condition: HIV; HIV Infections

NCT ID: NCT01118871

Effects of Mixed Exercise Regime and L-Carnitine Supplementation in HIV Patients on HAART

Condition: HIV Infections; Hyperlipidemia; Exercise

NCT ID: NCT00572429

Intermittent Therapy in HIV-1 Infected Patients With Successful Viral Suppression Under Highly Active Antiretroviral Therapy (HAART)

Condition: HIV Infections

NCT ID: NCT00122551

Efficacy of Using Interleukin-2 in Antiretroviral Naïve HIV Patients (ANRS119)

Condition: HIV Infections

NCT ID: NCT00120185

Study on the Antiviral Therapy and Immune Reconstitution of Chinese HIV/AIDS Patients

Condition: Acquired Immune Deficiency Syndrome; HIV Infections

NCT ID: NCT00872417

Observational Data Analysis in EuroSIDA (0518-058)

Condition: HIV-1 Infections

NCT ID: NCT01078233

Long-Term Supervised Treatment Interruption in HIV-Infected Patients

Condition: HIV Infections

NCT ID: NCT00118677

Comparison of Treatment Simplification by LPV/r vs Current Treatment Continuation in HIV-Infected Patients

Condition: HIV Infections

NCT ID: NCT00140751

Coronary Artery Disease and Its Association With Liver Steatosis Among HIV-Infected Persons

Condition: HIV Infections; Coronary Artery Disease; Non-Alcoholic Fatty Liver Disease

NCT ID: NCT00889577

Cohort of Young Adults Infected With HIV Since Birth or During Childhood

Condition: HIV Infection; Young Adult

NCT ID: NCT01269632

ALCAR Prophylaxis Study

Condition: HIV Infections; Distal Symmetric Polyneuropathy

NCT ID: NCT00225160

Effect of Omega 3 Fatty Acids on Oxidative Stress in HIV Seropositive Patients

Condition: HIV/AIDS

NCT ID: NCT02041520

A 72-week Randomized Clinical Trial Comparing the Safety and Efficacy of Three Initial Antiretroviral Regimens -GPO-VIR S (d4T/3TC/NVP) for 24 Weeks Followed by GPO-VIR Z (AZT/3TC/NVP) vs GPO-VIR Z vs TDF/FTC/NVP

Condition: HIV Infections

NCT ID: NCT00669487

Physiologic Investigation of the Renin Angiotensin Aldosterone Axis in HIV

Condition: HIV-infection

NCT ID: NCT01407237

Inflammation, Viral Replication, and Atherosclerosis in Treated HIV Infection

Condition: Atherosclerosis

NCT ID: NCT01519141

Evaluation of Viral Efficacy and Safety of a Reduced Dose of Stavudine (d4T): THE PHOENIX STUDY

Condition: HIV

NCT ID: NCT00235222

Comparing the Safety, Effectiveness, and Tolerability of Three Anti-HIV Drug Regimens for Treatment-Naive Patients

Condition: HIV Infections

NCT ID: NCT00050895

Safety and Immune Response of a Rotavirus Vaccine in HIV-infected and Uninfected Children Born to HIV-infected Mothers

Condition: HIV Infections

NCT ID: NCT00880698

Thalidomide for Treatment of Oral and Esophageal Aphthous Ulcers and HIV Viremia in Patients With HIV Infection

Condition: HIV Infections; Stomatitis, Aphthous

NCT ID: NCT00000790

Safety and Efficacy Trial of Serostim® in the Treatment of Subjects With Human Immunodeficiency Virus-associated Adipose Redistribution Syndrome (HARS)

Condition: Human Immunodeficiency Virus-associated Adipose Redistribution Syndrome (HARS); Human Immunodeficiency Virus Infections

NCT ID: NCT00294164

Study to Evaluate Changes in Limb Fat When Switching From a Thymidine Analogue

Condition: Lipodystrophy

NCT ID: NCT00647946

Adjunct Immunotherapy With Immunoxel in Patients With TB and TB/HIV

Condition: Tuberculosis; HIV

NCT ID: NCT01061593

Ethnicity Data in HIV Positive Men Who Have Sex With Men

Condition: HIV Infections

NCT ID: NCT01277458

Egrifta Replacement and Sleep Disordered Breathing

Condition: Lipodystrophy

NCT ID: NCT01788462

Omega-3 Supplementation and Depression Clinical Trial

Condition: Depressive Symptoms

NCT ID: NCT01614249

Cotrimoxazole Prophylaxis in Severely Malnourished Children

Condition: Nutrition Disorders; Life-threatening Infection

NCT ID: NCT00934492